nique (EMIT) [8][9][10] or by the sampling matrix used (blood or plasma).
Characteristics of patients
CsA determinations can also be influenced by the analytical method used: high performance liquid chromatography treated with CsA, first intravenously and then orally, is depicted in Figure 3 .
Discussion
CsA is mainly metabolized by the cytochrome P450 system in the liver and small intestine.
12-15 At least 30 metabolites of CsA have been found, 16 19 of which have been structurally identified.
17-21 The contribution of metabolites to CsA immunosuppressive activity and toxic effects is still under discussion. 22, 23 Metabolites are excreted primarily in the bile and only 6% in the urine. 24 The determination of single metabolite levels in biological fluids is necessary for a cor- measures the parent drug and its metabolites, has been proteins, haematocrit, haemoglobin. The results were reported as average values Ϯ s.e. The Student's t-test (paired) was used to assess the statistical significance of differences between the means. A value of P Ͻ 0.05 was considered statistically significant.
Results
In patients (five) who received CsA first as a bolus and then orally, the following values of P/M ratio were obtained (mean Ϯ s.e.): 1.81 Ϯ 0.10 (bolus); from 2.43 Ϯ 0.18 to 2.72 Ϯ 0.34 (oral administration) ( Figure 1 ).
In patients (10) treated with CsA by continuous infusion and thereafter orally, P/M ratios were (mean Ϯ s.e.): 1.77 Ϯ 0.19 (continuous infusion); from 2.26 Ϯ 0.12 to 2.78 Ϯ 0.42 (orally) (Figure 2) . No significant differences were found with regard to other parameters investigated (unreported data).
A representative follow-up profile of polyclonal and monoclonal trough concentrations obtained from a patient 
